Table 3.
Microglial activation and astrocytic GFAP expression in brains of LSD model mice.
Iba1 | GFAP | |||||||
---|---|---|---|---|---|---|---|---|
HC | CB | CX | BS | HC | CB | CX | BS | |
Gaucher | nc | nc | nc | nc | 0 | 0 | 0 | 0 |
Fabry | nc | nc | nc | nc | 0 | 0 | 0 | 0 |
Sandhoff | + | + | + | + | 0 | 100 | 60 | 0 |
NPA | ++ | ++ | ++ | ++ | 0 | 100 | 0 | 0 |
Hurler | + | + | + | + | 0 | 0 | 0 | 0 |
Pompe | ++ | ++ | ++ | ++ | 20 | 80 | 0 | 0 |
NPC | +++ | +++ | +++ | +++ | 0 | 60 | 0 | 0 |
Iba1 staining was assessed and compared to wild-type controls. GFAP immunoreactivity is quantified as percent of mice exhibiting increased signal in a particular brain area (n = 5/group, except Gaucher mouse model which was compared to historical controls (Sardi et al., 2011; Sardi et al., 2013). See Methods for experimental details regarding staining and blinded semiquantitative assessment. Abbreviations: Iba1: nc = no change compared to wild-type controls, + = mild activation, ++ = moderate activation, +++ = severe activation. GFAP: numbers show percentage of mice evaluated, which demonstrated increased astrogliosis.